 |
InterPro: IPR000961 AGC-kinase, C-terminal
Protein matches
|
UniProtKB Matches: 3012 proteins |
|
Accession
|
IPR000961 AGC-kinase_C |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Children
|
IPR017892 Protein kinase, C-terminal
|
|
Found in
|
IPR000239 GPCR kinase
IPR015743 Beta-adrenergic receptor kinase
IPR015751 Rho-associated coiled-coil containing protein kinase
IPR016232 cGMP-dependant protein kinase
IPR020684 Rho-associated coiled-coil containing protein kinase-like
|
GO Term annotation
|
|
Process
|
GO:0006468 protein amino acid phosphorylation
|
|
Function
|
GO:0004674 protein serine/threonine kinase activity
GO:0005524 ATP binding
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process.
Protein kinases fall into three broad classes, characterised with respect to substrate specificity [1]:
- Serine/threonine-protein kinases
- Tyrosine-protein kinases
- Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)
Protein kinase function has been evolutionarily conserved from Escherichia coli to human [2]. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation [3]. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [4], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [5].
The AGC (cAMP-dependent, cGMP-dependent and protein kinase C) protein kinase family embraces a collection of protein kinases that display a high degree of sequence similarity within their respective kinase domains. AGC kinase proteins are characterised by three conserved phosphorylation sites that critically regulate their function. The first one is located in an activation loop in the centre of the kinase domain. The two other phosphorylation sites are located outside the kinase domain in a conserved region on its C-terminal side, the AGC-kinase C-terminal domain. These sites serves as phosphorylation-regulated switches to control both intra- and inter-molecular interactions. Without these priming phosphorylations, the kinases are catalytically inactive [6, 7, 8].
Several structures of the AGC-kinase C-terminal domain have been solved. The first phosphorylation site is located in a turn motif, the second one at the end of the domain in an hydrophobic pocket. In PKB the phosphorylated hydrophobic motif engages a hydrophobic groove within the N-lobe of the kinase domain which orders alpha helices close to the active site [9].
|
Structural links
|
|
Database links
|
|
Example proteins
|
O00141 Serine/threonine-protein kinase Sgk1
O76360 cGMP-dependent protein kinase egl-4
P05130 Protein kinase C, brain isozyme
P05132 cAMP-dependent protein kinase catalytic subunit alpha
P06244 cAMP-dependent protein kinase type 1
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR002374 |
cGMP-dependent protein kinase, core |
 |
| IPR015745 |
Protein kinase C |
 |
| IPR014375 |
Protein kinase C, alpha/beta/gamma types |
 |
| IPR017441 |
Protein kinase, ATP binding site |
 |
| IPR017442 |
Serine/threonine-protein kinase-like domain |
 |
| IPR017892 |
Protein kinase, C-terminal |
 |
| IPR008973 |
C2 calcium/lipid-binding domain, CaLB |
 |
| IPR011009 |
Protein kinase-like domain |
 |
| IPR000719 |
Protein kinase, catalytic domain |
 |
| IPR002290 |
Serine/threonine-protein kinase domain |
 |
| IPR014710 |
RmlC-like jelly roll fold |
 |
| IPR002219 |
Protein kinase C-like, phorbol ester/diacylglycerol binding |
 |
| IPR020477 |
C2 region |
 |
| IPR000595 |
Cyclic nucleotide-binding |
 |
| IPR018029 |
C2 membrane targeting protein |
 |
| IPR020454 |
Diacylglycerol/phorbol-ester binding |
 |
| IPR018490 |
Cyclic nucleotide-binding-like |
 |
| IPR000008 |
C2 calcium-dependent membrane targeting |
 |
| IPR008271 |
Serine/threonine-protein kinase, active site |
 |
| IPR016232 |
cGMP-dependant protein kinase |
 |
| IPR018488 |
Cyclic nucleotide-binding, conserved site |
 |
| IPR000961 |
AGC-kinase, C-terminal |
 |
|
ModBase |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
SCOP Domain |
 |
|
Publications
|
|
1.
|
Hanks SK, Quinn AM, Hunter T.
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
Science 241 42-52 1988
[PubMed: 3291115]
http://www.sciencemag.org/cgi/content/abstract/241/4861/42
|
|
2.
|
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.
The protein kinase complement of the human genome.
Science 298 1912-34 2002
[PubMed: 12471243]
http://dx.doi.org/10.1126/science.1075762
|
|
3.
|
Manning G, Plowman GD, Hunter T, Sudarsanam S.
Evolution of protein kinase signaling from yeast to man.
Trends Biochem. Sci. 27 514-20 2002
[PubMed: 12368087]
http://dx.doi.org/10.1016/S0968-0004(02)02179-5
|
|
4.
|
Stout TJ, Foster PG, Matthews DJ.
High-throughput structural biology in drug discovery: protein kinases.
Curr. Pharm. Des. 10 1069-82 2004
[PubMed: 15078142]
http://dx.doi.org/10.2174/1381612043452695
|
|
5.
|
Li B, Liu Y, Uno T, Gray N.
Creating chemical diversity to target protein kinases.
Comb. Chem. High Throughput Screen. 7 453-72 2004
[PubMed: 15320712]
http://openurl.ingenta.com/content?genre=article&issn=1386-2073&volume=7&issue=5&spage=453
|
|
6.
|
Newton AC.
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.
Biochem. J. 370 361-71 2003
[PubMed: 12495431]
http://dx.doi.org/10.1042/BJ20021626
|
|
7.
|
Parker PJ, Parkinson SJ.
AGC protein kinase phosphorylation and protein kinase C.
Biochem. Soc. Trans. 29 860-3 2001
[PubMed: 11709088]
http://dx.doi.org/10.1042/0300-5127:0290860
|
|
8.
|
Mora A, Komander D, van Aalten DM, Alessi DR.
PDK1, the master regulator of AGC kinase signal transduction.
Semin. Cell Dev. Biol. 15 161-70 2004
[PubMed: 15209375]
http://dx.doi.org/10.1016/j.semcdb.2003.12.022
|
|
9.
|
Yang J, Cron P, Good VM, Thompson V, Hemmings BA, Barford D.
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.
Nat. Struct. Biol. 9 940-4 2002
[PubMed: 12434148]
http://dx.doi.org/10.1038/nsb870
|
Additional Reading
|
|
Heerding DA, Rhodes N, Leber JD, Clark TJ, Keenan RM, Lafrance LV, Li M, Safonov IG, Takata DT, Venslavsky JW, Yamashita DS, Choudhry AE, Copeland RA, Lai Z, Schaber MD, Tummino PJ, Strum SL, Wood ER, Duckett DR, Eberwein D, Knick VB, Lansing TJ, McConnell RT, Zhang S, Minthorn EA, Concha NO, Warren GL, Kumar R.
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.
J. Med. Chem. 51 2008 5663-79
[PubMed: 18800763]
http://dx.doi.org/10.1021/jm8004527
|
|
Strauss A, Fendrich G, Horisberger MA, Liebetanz J, Meyhack B, Schlaeppi JM, Schmitz R.
Improved expression of kinases in Baculovirus-infected insect cells upon addition of specific kinase inhibitors to the culture helpful for structural studies.
Protein Expr. Purif. 56 2007 167-76
[PubMed: 17720535]
http://dx.doi.org/10.1016/j.pep.2007.06.008
|
|
Rouse MB, Seefeld MA, Leber JD, McNulty KC, Sun L, Miller WH, Zhang S, Minthorn EA, Concha NO, Choudhry AE, Schaber MD, Heerding DA.
Aminofurazans as potent inhibitors of AKT kinase.
Bioorg. Med. Chem. Lett. 19 2009 1508-11
[PubMed: 19179070]
http://dx.doi.org/10.1016/j.bmcl.2009.01.002
|
|
Davies TG, Verdonk ML, Graham B, Saalau-Bethell S, Hamlett CC, McHardy T, Collins I, Garrett MD, Workman P, Woodhead SJ, Jhoti H, Barford D.
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.
J. Mol. Biol. 367 2007 882-94
[PubMed: 17275837]
http://dx.doi.org/10.1016/j.jmb.2007.01.004
|
|
Caldwell JJ, Davies TG, Donald A, McHardy T, Rowlands MG, Aherne GW, Hunter LK, Taylor K, Ruddle R, Raynaud FI, Verdonk M, Workman P, Garrett MD, Collins I.
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
J. Med. Chem. 51 2008 2147-57
[PubMed: 18345609]
http://dx.doi.org/10.1021/jm701437d
|
|